Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Voss

Showing results (231-240 of 274) with videos related to

Pageof 28
Sort By:
Nature Communications|October 19, 2019
Histone H3K23-specific acetylation by MORF is coupled to H3K14 acylationBrianna J Klein, Suk Min Jang, Catherine Lachance, et al.
Science (New York, N.Y.)|July 3, 2025
Relative importance of the anti-apoptotic versus apoptosis-unrelated functions of MCL-1 in vivoKerstin Brinkmann, Kate McArthur, Shezlie Malelang, et al.
Cancer Discovery|September 25, 2025
Functional Mapping of Epigenomic Regulators Uncovers Coordinated Tumor Suppression by the HBO1 and MLL1 ComplexesYuning J Tang, Haiqing Xu, Nicholas W Hughes, et al.
Leukemia|October 7, 2025
Clinical experience of using integrated whole genome and transcriptome sequencing as a framework for pediatric and adolescent acute myeloid leukemia diagnosis and risk assessmentRebecca K Voss, Victor B Pastor Loyola, Maria F Cardenas, et al.
Blood|February 14, 2019
PHF6 regulates hematopoietic stem and progenitor cells and its loss synergizes with expression of TLX3 to cause leukemiaHelen M McRae, Alexandra L Garnham, Yifang Hu, et al.
Leukemia|June 20, 2020
Synonymous GATA2 mutations result in selective loss of mutated RNA and are common in patients with GATA2 deficiencyEmilia J Kozyra, Victor B Pastor, Stylianos Lefkopoulos, et al.
Journal of Medicinal Chemistry|March 3, 2020
Discovery of Acylsulfonohydrazide-Derived Inhibitors of the Lysine Acetyltransferase, KAT6A, as Potent Senescence-Inducing Anti-Cancer AgentsDaniel L Priebbenow, David J Leaver, Nghi Nguyen, et al.
Nature Medicine|October 8, 2021
Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9/SAMD9L syndromesSushree S Sahoo, Victor B Pastor, Charnise Goodings, et al.
Nature|December 13, 2019
HBO1 is required for the maintenance of leukaemia stem cellsLaura MacPherson, Juliana Anokye, Miriam M Yeung, et al.
Nature Medicine|November 20, 2021
Publisher Correction: Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9/SAMD9L syndromesSushree S Sahoo, Victor B Pastor, Charnise Goodings, et al.
Pageof 28

Showing results (231-240 of 274) with videos related to

Sort By:
Pageof 28
Nature Communications|October 19, 2019
Histone H3K23-specific acetylation by MORF is coupled to H3K14 acylationBrianna J Klein, Suk Min Jang, Catherine Lachance, et al.
Science (New York, N.Y.)|July 3, 2025
Relative importance of the anti-apoptotic versus apoptosis-unrelated functions of MCL-1 in vivoKerstin Brinkmann, Kate McArthur, Shezlie Malelang, et al.
Cancer Discovery|September 25, 2025
Functional Mapping of Epigenomic Regulators Uncovers Coordinated Tumor Suppression by the HBO1 and MLL1 ComplexesYuning J Tang, Haiqing Xu, Nicholas W Hughes, et al.
Leukemia|October 7, 2025
Clinical experience of using integrated whole genome and transcriptome sequencing as a framework for pediatric and adolescent acute myeloid leukemia diagnosis and risk assessmentRebecca K Voss, Victor B Pastor Loyola, Maria F Cardenas, et al.
Blood|February 14, 2019
PHF6 regulates hematopoietic stem and progenitor cells and its loss synergizes with expression of TLX3 to cause leukemiaHelen M McRae, Alexandra L Garnham, Yifang Hu, et al.
Leukemia|June 20, 2020
Synonymous GATA2 mutations result in selective loss of mutated RNA and are common in patients with GATA2 deficiencyEmilia J Kozyra, Victor B Pastor, Stylianos Lefkopoulos, et al.
Journal of Medicinal Chemistry|March 3, 2020
Discovery of Acylsulfonohydrazide-Derived Inhibitors of the Lysine Acetyltransferase, KAT6A, as Potent Senescence-Inducing Anti-Cancer AgentsDaniel L Priebbenow, David J Leaver, Nghi Nguyen, et al.
Nature Medicine|October 8, 2021
Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9/SAMD9L syndromesSushree S Sahoo, Victor B Pastor, Charnise Goodings, et al.
Nature|December 13, 2019
HBO1 is required for the maintenance of leukaemia stem cellsLaura MacPherson, Juliana Anokye, Miriam M Yeung, et al.
Nature Medicine|November 20, 2021
Publisher Correction: Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9/SAMD9L syndromesSushree S Sahoo, Victor B Pastor, Charnise Goodings, et al.
Pageof 28